NextCure (Series A, Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- January 06, 2016
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $160,000,000
Company Info
- Founding Year
- 2015
- Founders
- Michael Richman
- Company Description
- NextCure, launched in 2015, is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.
- Market
- Immuno-oncology
- Location
- New Haven, CT, USA
- Coinvestors
- Canaan Partners, Lilly Asia Ventures, OrbiMed Advisors, Pfizer Strategic Investments Group, Sofinnova Ventures, ArrowMark Partners, Bay City Capital, Hillhouse Capital Management, NS Investment, Pfizer Venture Investments, Ping An Ventures, Quan Capital, Surveyor Capital, Taiho Ventures